Cannabis news and culture outlets like us do our very best to cover groundbreaking information related to our precious flower. This is especially true when it comes to medical science breakthroughs, as therapeutic uses of pot are both numerous and vital when it comes to the well-being of our society. Yet, the struggle for cannabis acceptance means that some of the data will slip through our fingers if mainstream or independent cannabis outlets are not made privy to the developments for a myriad of reasons. So, to maintain our due diligence, here are two significant anti-cancer medical cannabis studies that went largely unnoticed.
The Madrid study
The Nature Cancer Review Journal published a 2000 study conducted by researchers in Madrid, Spain which found that incurable brain tumors in rats were completely eradicated by THC injections. Manuel Guzman, lead researcher of the study discovered that cannabinoids impeded tumor growth.
These compounds have been shown to inhibit the growth of tumor cells in culture and animal models by modulating key cell-signaling pathways. Cannabinoids are usually well tolerated, and do not produce the generalized toxic effects of conventional chemotherapies.
The finding was significant since cancer cells multiply exponentially. Cannabinoids cause cancer cell death, while also inhibiting angiogenesis – the formation of new blood vessels that can keep tumors growing strong. This study was not covered by any major news outlet in the U.S.
The Virginia study
A previous effort to tie cannabis to effective cancer treatment was conducted in 1974 at the Medical College of Virginia. At the time, the National Institute of Health funded the study in order to uncover evidence that THC had a detrimental impact on the immune system.
However, the opposite impact was found when researchers concluded that THC decelerated the growth of a variety of cancers in rodents (including leukemia). The only article to cover a small portion of the research appeared in the local section of the Washington Post that same year.
The active chemical agent in marijuana curbs the growth of three kinds of cancer in mice and may also suppress the immunity reaction that causes rejection of organ transplants, a Medical College of Virginia team has discovered.
The researchers “found that THC slowed the growth of lung cancers, breast cancers and virus-induced leukemia in laboratory mice, and prolonged their lives by as much as 36 percent,” read the piece.
A scheme of the highest magnitude
Going further than a mere media blackout, the DEA ultimately stepped in and ended this study. It is reported that President Gerald Ford demanded that pharmaceutical companies had exclusive rights to cannabis research in order to develop synthetic versions of THC.
Eventually, a compelling article titled, “Pot Shrinks Tumors; Government Knew in ‘74’ was published in the San Antonio post detailing the Virginia study and how it was suppressed by the mainstream media.
Call it a conspiracy if you want, but media blackouts of important cannabis research are bound to happen in a country where harmful, for-profit prescription drugs are placed at the forefront of healthcare. You don’t have to be high to connect these dots, that’s for sure.
This post was originally published at this location